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Biopsies are one of the most effective and least invasive methods of diagnosing renal 
diseases.  Without a sample of kidney tissue, Nephrologists are not able to properly 
diagnose a patient, leading to incorrect or delayed treatment.  However, if a patient is at 
high risk for excessive bleeding, a physician may be hesitant to perform a biopsy.  The 
kidneys are deep solid organs, and if bleeding occurs through a biopsy site, doctors have 
no way of stopping the bleeding.  Therefore, in patients with high blood pressure or 
conditions causing a low platelet count, this bleeding could become life threatening. 
 
The solution to this problem, as proposed by Dr. William Weitzel in the Nephrology 
department at the University of Michigan health system, is a biopsy device that will 
remove a sample of kidney tissue and immediately deploy a hemostatic (blood-stopping) 
agent in the cavity. This agent is left in order to stop excessive bleeding from occurring.  
No existing biopsy device on the market offers this novel component, and it would be 
very beneficial for medical professionals.  This design would be advantageous for all 
biopsy procedures, but particularly in the kidneys, where blood flow is higher than in 
most regions of the body. 
 
In talking to Dr. Weitzel and focusing on the crucial engineering specifications, we 
combined our preliminary concept sketches for each biopsy device subfunction to make 
three full product assemblies of possible biopsy devices.  From these designs, we selected 
our alpha biopsy device design: a needle that deploys a Gelfoam® plug by creating fluid 
pressure behind the plug after the kidney sample is captured.  We feel that this design 
best fits the customer needs supplied by Dr. Weitzel, and is also the most manufacturable 
of our biopsy device concepts. 
 
To determine the best material choices, we ran a series of tests and mechanical analyses 
on the potential weak points of the design.  From the tests on the BARD® Monopty® 
device, we determined the appropriate spring forces needed to puncture a kidney, and 
also determined the necessary spring force to drive a Gelfoam® plug out of the tip of the 
needle using a hydraulic system.  These force measurements, when inserted into the CES 
Edupack filter led us to pick Delrin plastic for our parts and type 304 Stainless Steel for 
our needles and springs.  The Delrin plastic was injection molded, and the steel needles 
were hot metal extruded.  The springs were bought through a third party supplier. 
 
We created a working prototype and verified it functionality through a series of tests.  We 
were able to fire our inner needle and outer sheath consecutively, and immediately retract 
both simultaneously.  Also, we were able to expel a fluid out of the tip of our needle after 
firing the device.  Thirdly, we were able to insert a small piece of Gelfoam® into a 
kidney-like material.  Each of these successful tests proved that our device will work the 
way that we designed it to.  We were not able to use the device to take a sample of kidney 
tissue and deploy a hemostatic plug due to issues with our needle tip leaking from the 
collection site and our fluid plunger locking up, but we are confident that our device will 
function as designed after further work is put into developing some aspects of the design.  
Our device will be effective in preventing significant bleeding after biopsy. 
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1.0   PROBLEM DESCRIPTION 
 
Kidney biopsies are a very important procedure for the diagnosis of renal diseases.  
However, due to the high blood flow to the area, Nephrologists are hesitant to perform 
biopsies on patients who are at high risk for bleeding problems.  Without a kidney 
biopsy, making an accurate diagnosis is difficult and proper treatment can be hindered.  
The current preferred biopsy method is a percutaneous biopsy, as it minimally invasive 
with low morbidity.  However, if a patient has a bleeding condition, the small hole left by 
this procedure can be enough to create a serious bleeding problem [1].  While this is not 
common, it can become life-threatening in such patients.   
 
Our solution to this problem, as proposed by Dr. William Weitzel in the Nephrology 
department at the University of Michigan, is to create a biopsy device that takes a sample 
of kidney tissue and then immediately fills the biopsy “hole” with a hemostatic agent to 
stop any bleeding problems from occurring.  This design would be beneficial to any deep 
solid organ biopsy procedure, as it would greatly reduce the risk of any serious bleeding 
problem occurring. 
 
The needle will stop bleeding by deploying a core of a hemostatic agent in the cavity left 
by the biopsy needle immediately after the kidney sample is retracted into the sheath of 
the needle.  The typical biopsy device design is a two-step mechanism to cut and then 
collect the biopsy.  Our design will add a third step of leaving a plug to stop bleeding in 
the biopsy site.  This needle design will have all of the advantages of a minimally 
invasive percutaneous design while preventing its major flaw: excessive bleeding.  This 
will increase patient safety and the rate of biopsies performed, therefore increasing the 
successful diagnosis and treatment of kidney disease. 
 
2.0   BENCHMARKING 
 
In order to better understand the task at hand, benchmarking of biopsy procedures, 
devices, and hemostatic methods was performed. 
 
2.1   Percutaneous Procedure 
 
The current biopsy method is percutaneous biopsy, or a biopsy through the skin directly 
into the kidney.  For this method, Nephrologists at the University of Michigan health 
system use a Monopty® device (BARD® Pat.).  This device has a needle that is inserted 
8-10 centimeters into the skin until the physician can feel the hard, outer cortex of the 
kidney.  Once the needle is in this position, its mechanism is triggered to remove a small 
tissue sample from the cortex. 
 
In talking with Dr. Weitzel, we found out that this is the highly preferred method for 
kidney biopsy by Nephrologists because it is minimally invasive to the patient.  It is the 
most direct method to take a kidney biopsy, and its success rate for taking a usable 
sample from the cortex is high.  However, this procedure involves the puncture of a deep 
solid organ, meaning that there is no direct access to the wound if heavy bleeding occurs.  
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This is a risk that doctors sometimes are not willing to take if a patient’s life could be in 
danger from excessive bleeding. 
 
2.2   Current Preferred Biopsy Device 
 
Nephrologists at The University of Michigan Hospitals currently prefer to use BARD® 
Monopty® brand biopsy devices as shown in Figure 1 below.   
 
 
Figure 1:  BARD® Monopty® biopsy device 
 
These devices require three steps to complete the tissue collection procedure, and can be 
deployed with a simple, one-handed operation.  In order to prepare for tissue collection, 
the doctor first rotates the outer handle to cock the outer cutting sheath.  The doctor then 
continues to rotate the handle to cock the inner collection needle.  The doctor then inserts 
the needle into the patient’s lower back and positions the tip of the needle just outside of 
the outer cortex of the kidney.  Next, the doctor presses the release trigger which first 
deploys the inner collection needle, immediately followed by the outer cutting sheath.  
The doctor then manually removes the needle from the kidney and body of the patient.  
The Figures 2.a, 2.b, and 2.c show the how the device operates to collect a sample.  (Note 
that these models do not show the springs that provide the forces for needle deployment, 
or the outer rotating handle used to retract the needles and initiate the device).  
 
 
Figure 2.a:  BARD® Monopty® biopsy device placed outside of kidney cortex 
Release trigger 
Model of kidney 
Rotating outer handle 
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Figure 2.b: Inner collection needle deployed into kidney tissue 
 
 
Figure 2.c: Outer cutting sheath deployed into kidney tissue 
 
2.3   Kidney Characteristics 
 
We need to have an understanding of the kidney anatomy, the kidney tissue desired for 
biopsy, and also its functional processes in order to create a safe and effective biopsy 
device.  Dr. Weitzel shared all of this information with us (unless otherwise noted), as he 
has an extensive knowledge of the kidneys.   
• Location:  The two kidneys lie just above the waist and below the diaphragm.  
They are located 8-10 cm deep, depending on patient size, within the abdominal 
cavity when measured from the back. 
• Material properties:   Density = 1050 kg/m3, Bulk modulus = 2500 MPa, Young’s 
modulus = 1.2 MPa [2].  
• Size:   The typical adult kidney size is 10-12 cm in length, 5-7 cm wide, and 3 cm 
thick, with a mass of 135-50 g [2].  The tissue required for biopsy must be 
obtained from the kidney cortex, or outer layer.  We found a value for the mean 
kidney cortex thickness to be 0.72+/-0.14 cm [3].   
• Purpose:  The kidney’s main purpose is to filter the blood and excrete waste, 
along with water, as urine.  The kidney also serves to regulate blood pressure, 




Outer cutting sheath  
is deployed second 
Inner collection needle mount 
feature triggers outer cutting  
sheath deployment 
Inner collection needle 
deployed first 
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2.4   Hemostatic Methods 
 
Determining current hemostatic methods, and gaining a better understanding of these 
methods, would benefit us in our development of the hemostatic component to our biopsy 
device.  We obtained the information on these methods from Dr. Weitzel. 
 
• Gelfoam® (compressed sponge):  Gelfoam® is a hemostatic substance that is 
used in medical procedures to assist in the coagulation of blood.  Gelfoam® itself 
can hold up to 45 times the volume of its original shape.  Gelfoam® is unique in 
that it can be used with or without thrombin, which is described below.   
• Suturing Devices:  Closing the wound with a suture (stitch) or multiple sutures is 
one method to help stop bleeding.  The sutures may be dissolvable or manually 
removed.  On the kidney, sutures are currently used in the open biopsy procedure.  
• Cauterizing:  Electrocautery and Chemical Cauterization are two methods by 
which tissue is burned and are frequently used to stop the bleeding of small blood 
vessels.  Electrocautery is generally preferred to Chemical Cauterization because 
the dispersion of Chemicals within the body is difficult to predict and control, 
which could lead to unwanted cauterization. 
• Fibrin (clotting stimulant):  A protein that, when in the presence of blood 
platelets, forms a mesh for a blood clot.  Fibrin is naturally found in blood. 
• Fabric coil:  A metal or fabric coil may be introduced in order to act as a structure 
for and facilitate clotting.  The metal may remain permanently in the body or a 
biodegradable alternative material may be suggested. 
• Thrombin:  Thrombin is a protein found in blood.  This protein converts 
fibrinogen from the blood into strands of fibrin.  Methods currently used include 
prothrombin complex concentrate and fresh frozen plasma [5].  
 
2.5   Transjugular Procedure 
 
One alternative to a percutaneous kidney biopsy is a transjugular kidney biopsy [6].  This 
procedure is a method of taking a biopsy by running a long, thin catheter from the jugular 
vein in the neck all the way down to the kidney.  Once the catheter has reached the 
kidney, a small needle at the tip is used to cut and remove a sample from the area.  This 
sample is then pulled back out through the neck. 
 
However, this method cannot be considered a serious alternative to the percutaneous 
approach [7].  This is because of issues of personnel, time, cost, and morbidity.  An 
experienced angiographer is required for the procedure, which is much longer and 
costlier than the percutaneous biopsy procedure.  Also, the desired region for sampling in 
the kidney is the outer layer, called the cortex.  A transjugular biopsy needle must go 
through the interior of the kidney to reach the cortex.  This leads to greater chance of 
unusable tissue samples and more damage done to the interior of the kidney. 
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2.6   Open Biopsy Procedure 
 
Another alternative to the percutaneous biopsy method is open biopsy.  Open biopsy is 
surgery to get a sample of kidney tissue.  The reason that it may be used is that the site of 
bleeding is exposed, and doctors can stop bleeding directly, if it is deemed necessary.  
This is a last resort for doctors, as it is much more costly and invasive than any other 
biopsy method.  The time required in preparation for surgery and observation of the 
patient after surgery is long and expensive. 
 
2.7   Angiogram Procedure 
 
An angiogram is simply an x-ray of the blood vessels in a body focusing on arteries, 
veins, or the heart. A catheter is threaded through the arteries and an x-ray contrast is 
administered. The blood flow can then be monitored by the images obtained by the x-ray. 
In the case of the kidney biopsy, an angiogram is done to see how much bleeding has 
occurred in the kidney as a result of the biopsy. If necessary, a hemostatic agent (most 
frequently Gelfoam®) can be threaded through the catheter and deployed in the blood 
stream to stop excessive bleeding.  
 
2.8   Other Patents 
 
US Patent #5,487,392 held by John R. Haaga describes a device that is similar to the 
currently used BARD® Monopty®, but is designed to deposit a semi-circular hemostatic 
insert into the biopsy site upon removal of the needle.  This design does not protect the 
hemostatic insert during the procedure, and functions with the insert being in direct 
contact with kidney tissue throughout the needle insertion process.  We believe this could 
cause damage to the insert.  Our design will differ in this aspect, as we plan to provide 
protection for our bleeding control agent.  We believe that this will allow our design to be 
a more reliable device that does not have the risk of causing damage to the bleeding 
control agent and ensures bleeding stoppage every time. 
 
US Patent #5,080,655 – Medical Biopsy Needle – John R. Haaga 
This device is designed to have a bioabsorbable gelatin needle tip which is deposited and 
left behind during a biopsy procedure.  This tip acts to help control bleeding following 
the procedure. 
 
US Patent #4,838,280 – Hemostatic Sheath for a Biopsy Needle and Method of Use – 
John R. Haaga 
This design is similar to Haaga’s design described in US Patent #5,487,392.   
 
US Patent #7,220,266 – Tissue Capturing and Suturing Device and Method – Richard A. 
Gambale 
This device is used for endoscopic procedures, typically in the gastro-esophageal tract.  
The design incorporates a tissue sewing feature on the end of the needle. 
 
US Patent #7,232,421 – Agent Delivery Systems – Richard A. Gambale, et. al. 
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This invention is designed to deliver a therapeutic substance in the form of a pellet into 
tissue.  The design allows blood to pool around the pellet to mix with the substance. 
 
US Patent #5,858,781 – Method of Tissue Transfer and Retrieval – John R. Matyas, et. 
al. 
This patent describes a method of transferring intact cells from the surface of organ tissue 
to a damaged or non-intact tissue area. 
 
US Patent #5,993,399 – Automated Tissue Sampling Device – Pruitt, et. al. 
This device is similar to the currently used BARD® Monopty® design.  It requires three 
steps to operate, and collects a sample with a simple, one-handed operation. 
 
US Patent #5,876,354 – Biopsy Needle Hub Assembly – Brad Quinn, et. al. 
This design is similar to the currently used BARD® Monopty® design, but uses 
disposable needles and a permanent housing. 
 
US Patent #7,097,637 – Safety Needle with Positive Flush – Daniel J. Triplett, et. al. 
This device is designed to deposit a fluid through a needle as it is withdrawn from a 
vascular access port. 
 
US Patent #6,546,276 – Ultrasonic Based Detection of Interventional Medical Device 
Contact and Alignment – Claudio I. Zanelli 
This is a device and method that can be used to monitor the location of medical device 
within the body through ultrasonic signals.  Accurate position and alignment monitoring 
of medical devices with tissue is possible with this device. 
 
3.0   CUSTOMER REQUIREMENTS AND ENGINEERING 
SPECIFICATIONS 
 
3.1   Customer Requirements 
 
Our meetings with Dr. Weitzel and Dr. Rao gave us a very clear set of customer needs 
upon which to base our design.  We determined that some of the key requirements 
include that the device stops bleeding, is easy to operate, is reliable, and collects a 
sufficient tissue sample every time.  The complete list of requirements can be seen in 
Table 1.  All requirements are rated on a scale of 1-10 with 10 corresponding to the 
highest level of importance 
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Customer Requirements Weight
Minimally invasive 7 
Stops bleeding 10 
Low noise 4 
Easy to maneuver - lightweight/balance 9 
One handed ambidextrous operation 9 
Fast operation 8 
Re-usable 2 
Easy to operate 8 
Obtains sufficient sample every time 9 
Robust/Durable 5 
Reliable 9 
Has long shelf life 4 
Low cost 2 
Table 1:  Customer requirements 
 
3.2   Engineering Specifications 
 
After examination of the current biopsy device, we determined that the engineering 
specifications that we need to design to are as follows: 
1. Needle length 
2. Needle width 
3. Handle length 
4. Handle width 
5. Number of parts 
6. Sample collection capacity 
7. Number of steps to operate 
8. Force of collection mechanism 
9. Mass 
10. Minimum force required to operate 
11. Lifetime (cycles) 
12. Operation time 
13. Flexibility of needle 
 
We developed this list by determining the design features that would need to be 
controlled to satisfy the customer requirements.  For example, in order for our design to 
be minimally invasive, we need to control the size of the needle and the operation time.  
For our design to be easy to maneuver and operate, we need to control features such as 
the number of steps to operate, the mass, and the minimum force to operate the device. 
 
3.3   Results of Quality Function Deployment (QFD) 
 
Our QFD diagram allowed us to determine the most important aspects of our design and 
gave us an idea of where our priorities should lie.  By determining the level of 
relationship between each of our customer requirements and engineering specifications, 
we were able to assign importance rankings to each of our engineering specifications.  
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We discovered that the number of parts, the number of steps to operate, and the needle 
width were the most important design features that we should focus on.  Our complete 
QFD can be seen in Appendix A. 
 
4.0   CONCEPT GENERATION 
 
Our first goal was to generate many ideas for our advanced biopsy needle to form a 
strong conceptual base from which we could develop our alpha design.  During the 
process of generating concepts, we divided our designs into two major subfunctions: first, 
the actual needle that punctures the kidney and extracts tissue; second, the external 
mechanism which deploys the needle. 
 
Within the needle subfunction, our concepts were further broken into two categories. The 
first category consists of designs that feature a tissue collection mechanism based upon 
the existing BARD® Monopty® needle, where the inner collection needle features a 
depression into which the kidney tissue can fold and be quickly cut from surrounding 
tissue by the outer cutting sheath. We adapted this design to include the insertion of a 
hemostatic core. One concept within this category includes the addition of a hemostatic 
agent insertion channel to the existing inner collection needle.  Another utilizes the 
existing tip geometry and widens to a dual-channel, revolver-like mechanism for 
deploying both the inner collection needle and the hemostatic agent.  Additional BARD® 
Monopty®-derived concepts and variations on these designs exist in this category as 
well. 
 
The second category of needle-subfunction designs features a complete redesign of the 
tip of the needle. These designs include such ideas as a rotating needle that displaces a 
hemostatic agent into the kidney and then rotates to collect a sample, a suctioning hole to 
grab kidney tissue, as well as a needle tip which teeth to pull tissue inwards upon removal 
from the kidney, while pushing Gelfoam® out. 
 
Within the handle subfunction, concepts were also broken into two categories.  The first 
category utilizes mechanical deployment of the needle.  Concepts within this category 
include springs and pushing rods to deploy the cutting mechanism and insert a hemostatic 
agent.  The second category of concepts accomplishes the same tasks through use of a 
fluid or fluid and mechanical mechanism.  All of these designs are shown in further detail 
in our preliminary ideas section. 
 
5.0   PRELIMINARY IDEAS 
 
5.1   Rotating, Gelfoam®-ejecting Mechanism 1 
 
This design is an attempt to maximize the volume of the tissue collection site while still 
providing space to hold the Gelfoam® prior to deployment.  The needle would deploy 
into the kidney and quickly rotate 360 degrees as indicated in the sketch.  The edge of the 
tissue collection site would be sharp and angled so as to draw the tissue into the cavity of 
the needle.  When the needle has rotated 360 degrees, the needle would retract while the 
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Gelfoam® ‘plug’ is deployed at the same rate in the opposite direction.  This could be 
accomplished by a spring connecting the two mechanisms within the handle.  This would 
result in the Gelfoam® being ejected to the exact position of the hole. 
 
Figure 3:  Rotating, Gelfoam®-ejecting Mechanism 1 
5.2   Rotating, Gelfoam®-ejecting Mechanism 2 
 
This design is similar to the previous design except it places the Gelfoam® below (or 
further into the kidney than) the tissue collection site.  This would allow the design of a 
narrower needle.  The tissue collection site would have a small cutting hole that is very 
sharp and angled in order to draw the tissue up and into the device.  After a 360-degree 
rotation the Gelfoam® would be deployed in a manner similar to that described in the 
previous design.  This design could also utilize a vacuum to assist in drawing the kidney 
tissue into the needle. 
 
Figure 4:  Rotating, Gelfoam®-ejecting Mechanism 2 
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5.3   Dual-Channel Needle Design 
 
 
Figure 5:  Dual-Channel Design 
 
This concept uses two channels within the outer cutting sheath that allows for the 
collection needle to travel as in the current BARD® Monopty® device, and for a plunger 
to travel down a second channel to push out the hemostatic agent.  The needle would be 
thicker near the device, and be the standard 16-gauge size where there is the 22mm 
penetration of the kidney tissue.  The second channel allows for a larger amount of 
hemostatic agent to be applied, since the inner collection needle could be retracted back 
and the entire outer cutting sheath diameter would be open for use.  Potential concerns 
with this design are how the larger area of the needle would affect muscle tissue, and if 
there would be a chance that this larger area could ever travel into the kidney tissue. 
 
5.4   Manual Inner Plunger Design 
 
 
Figure 6:  Manual Inner Plunger Design 
 
This device would require that the doctor manually push a slider upon removal of the 
needle from the kidney that would deposit the hemostatic agent.  A major concern with 
this design is that the doctor would need to correspond the pushing of the slider with 
removal of the needle from the kidney tissue.  There could be uncertainty of whether or 
not the agent was deposited correctly. 
 
5.5   Reverse Cut Needle Tip 
 
 
Figure 7:  Reverse Cut Needle Tip 
 
This needle would sample tissue by cutting it on removal of the needle from the kidney.  
As the sample is deposited in the needle tip, it would push out a hemostatic agent that 
would fill the sample hole. 
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5.6   Hydraulic Injection of Gelfoam® 
 
This design uses a spring loaded retracting mechanism to eject a set amount of hydraulic 
solution to push out a core of Gelfoam®.  Instead of using a piston-plunger type 
mechanism to push the Gelfoam® plug into the cavity left by the biopsy, the retracting of 
the needle and sheath from the kidney would compress a small container of fluid in the 
handle of the device.  This compression would then send fluid down the needle behind 
the pre-loaded Gelfoam® core.  
 
Figure 8:  Hydraulic Injection Design 
 
5.7   Needle Twist Design 
 
The needle twist design of the biopsy device makes a small adjustment to the existing 
BARD® design to allow for deployment of a hemostatic agent.  The Monopty® needle is 
pre-loaded with a core of Gelfoam® in the cavity used to collect kidney samples in the 
stylet needle.  When the needle plunges into the kidney, it carries the Gelfoam® with it.  
At the very bottom of the motion, the needle twists, cutting the kidney sample, and 
wiping the Gelfoam® out of the needle.  The outer sheath then fires into the kidney, 
cutting and collecting the kidney sample, while the hemostatic remains outside of the 
assembly.  The needle is removed manually, and the Gelfoam® is left in the biopsy hole. 
 
 
Figure 9: Needle Twist Design 
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5.8   Cauterization 
 
This idea involves the concept of electro cauterization.  This uses a design similar to the 
BARD® biopsy device with an electric probe added to the tip and wired within non-
conductive material to an electrical source within, or attached to, the handle.  The needle 
would be deployed in a similar matter to the current design.  At the instant the cutting 
sheath is deployed, an impulse of electrical current would be sent through the conductive 
wiring to the probe.  This would serve to cauterize the local tissue and prevent bleeding.  
The needle would be removed in the same manner as the BARD® device. 
 
Figure 10:  Cauterization Design 
 
5.9   Fluid Injection Design 
 
In order to maximize the tissue collection site volume, the hemostatic agent could be 
introduced through a tiny needle (or tube) embedded in the biopsy device.  Dissolved 
Gelfoam®, fibrin, thrombin, or another liquid hemostatic agent could be injected through 




Figure 11: Fluid Injection Design 
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5.10   Revolving Needle Design 
 
This design includes a four part process in accomplishing the goal of performing the 
extraction of tissue and deploying Gelfoam® into the kidney. The first step is very 
similar to the BARD® Monopty® design. An inner collection needle  and cutting sheath 
are deployed into the kidney. 
 
 
Figure 12.a: Preloaded Revolving Needle Design 
 
The next step in the process is that the inner collection needle retracts completely into the 
handle of the Revolving Needle Design. 
 
 
Figure 12.b: Needle Retraction 
 
The Gelfoam® insert now rotates into place where it can be deployed. 
 
 
Figure 12.c: Rotation 
 
Finally, the Gelfoam® core is injected into to the kidney. 
 
 
Figure 12.d: Injection 
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6.0   CONCEPT REFINEMENT 
 
After going through the concept generation process, we determined the most important 
factors that needed to be incorporated into our design.  From our customer requirements 
and engineering specifications as documented in our QFD we developed three refined 
ideas. 
 
6.1   Fluid Injection Design 
 
The first design is one that uses fluid pressure to inject a plug of Gelfoam® out of the tip 
of the needle.  The mechanism has a rear-facing spring to retract the needles and also 
compress a container of fluid to send fluid down the needle, pushing a pre-loaded 
Gelfoam® plug out of the needle tip.  To retract the needles from the kidney, they must 
be first detached from the springs used to plunge them into the kidneys, and then fired 
back with the rear-facing spring.  To detach the needles, a novel rotating design is used.  
The forward-firing springs push on a cylinder inside of another shell to which the needles 
are attached.  A helical contour on the inside of the handle then unlocks the outer 
cylindrical shells from the inner cylinder as they fire down the handle, releasing the 
needles from the first set of springs.  Once this release has taken place, the needles can be 
retracted out of the kidney.  This design is diagrammed in Figure 13, below. 
 
Figure 13: Fluid Injection Design 
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6.2   Torsional Spring Design 
 
The second design looks to achieve our main goals in a much different way than that of 
our first Fluid Injection Design. The first major design change is to use a torsional spring 
instead of a more traditional spring. This torsional spring would turn a spool of wire that 
would push down the inside of the inner collection needle and insert the Gelfoam®.  
After the tissue collection takes place, a shaft would rotate and pull two stoppers out of 
the way that would retract the needles and release the torsional spring.  A major problem 
with this design however is that the Gelfoam® is deployed by a solid rod, which could 
result in a less robust device due to the small rod diameter required.  This design is shown 
in Figure 14, below. 
 
 
Figure 14: Torsional Spring Design  
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6.3   Dual Release Design 
 
The dual release design features the use of the spring-loaded mechanism found currently 
in the BARD® Monopty® biopsy device.  Our design expands upon the current device 
with the addition of two mechanisms.  One of these is a spring-loaded plunger for the 
ejection of Gelfoam® into the kidney.  The other is a spring-loaded mechanism to retract 
both the tissue collection needle and cutting sheath after their deployment into the kidney.  
The push of a single button would trigger the release of both the tissue collection needle 
and the Gelfoam®-ejecting plunger, hence the name ‘Dual Release Design’.  The 
deployment of the tissue collection needle triggers the cutting sheath deployment, which 
then triggers a retraction mechanism.  The simultaneous but separate deployment of the 
two initial mechanisms allows the collection needle and cutting sheath to be retracted 
while the plunger remains extended, therefore ejecting the Gelfoam® into the wound site.  
For a diagram of this model, see Figure 15, below. 
 
 
Figure 15: Dual Release Design 
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7.0   SELECTION OF ALPHA DESIGN 
 
We drew upon our customer requirements and engineering specifications (as documented 
in our QFD in Appendix A) to perform both qualitative and quantitative analysis in order 
to select the best design as our alpha design. 
 
7.1   Qualitative Assessment: Pro-Con Analysis 
 
We extensively examined each of these designs and compared the pros and cons of each.  
Our results are documented in Table 2, below. 
 
Design Advantages Disadvantages 
Design 1:  Fluid Injection • Amount of gel-foam 
deposited is adjustable 
• Small number of moving 
parts needed 
• Eliminates need for very 
small gel-foam depositing 
plunger shaft 
• May be difficult to re-load 
for multiple collections 
• May require safety 
precautions to ensure no air 
is in fluid lines 
• May leak or pre-expand gel-
foam before depositing 
Design 2:  Torsional 
Spring 
• Amount of gel-foam 
deposited is adjustable 
• Fully mechanical gel-
foam depositing 
mechanism 
• Gel-foam depositing 
mechanism minimizes 
space required to fit 
within housing 
• May be difficult to re-load 
for multiple collections 
• Rotating spool may result in 
kinking or breakage of gel-
foam plunger 
• Moderate number of 
moving parts needed 
Design 3:  Dual-release • Simple, fully mechanical 
operation 
• Small number of parts 
needed 
• Common parts used – 
reduced tooling required 
• Large housing required to 
fit parts 
• High force required in 
retraction mechanism 
• Manufacturing/assembly 
may be difficult 
Table 2: Pros and cons of final designs 
 
From this analysis we concluded that the Fluid Injection Design contained the most 
positive design aspects and would be the easiest to manufacture.  All of the designs are 
effective designs; however, the Fluid Injection Design does everything we need in a 
simple and innovative manner. 
 
7.2   Quantitative Assessment: Pugh Analysis 
 
We also used a Pugh analysis to determine which of our designs best fits the customer 
and engineering demands of a biopsy device with bleeding control.  The Pugh analysis 
compares how well each concept satisfies customer and engineering needs in a Boolean 
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fashion.  If a concept does a better job satisfying a particular design specification than the 
benchmark, it receives a plus (+) and a minus (-) if it is worse.  The total number of 
pluses and minuses from each weighted row are totaled, giving a total satisfaction value.  
The Pugh chart can be seen in Table 3, below.  In this chart, design 1 is our dual-
releasing mechanism, design 2 is our design with a sliding rod release mechanism, and 
design 3 is the fluid injection mechanism.  The initial goals (datum) category represents 
the current technology of the BARD® Monopty® biopsy device.  As a team, we decided 
how each of the three concepts compared to our original goals for the project, and how 
they compared to the BARD® Monopty® needle when applicable, as the BARD® design 
does not include bleeding control.   
 
Design Criteria Weight* Design 1 Design 2 Design 3 
Initial goals 
(datum) 
Stops bleeding 10 + + + 0 
Manufacturability 8 0 - - 0 
Easy to maneuver 
and operate 9 0 0 0 0 
Simple 
mechanism 
operation 8 - - 0 0 
Re-usable 2 0 - 0 0 
Few parts 7 + - 0 0 
Obtains sufficient 
sample 10 0 0 0 0 
Robust/Durable 
mechanism 6 + - 0 0 
      
 + 23 10 10  
 0 29 19 42  
 - 8 31 8  
 Total 15 -21 2  
 Ranking 1 3 2  
      
      
    
Table 3: Pugh analysis for alpha design selection 
 
The Pugh analysis allowed us to subjectively but quantitatively determine which of our 
three design possibilities was the best choice for our alpha design.  This analysis resulted 
in the Fluid Injection Design to be the best choice for our advanced biopsy device.  While 
the Pugh analysis was not the sole reason for choosing this option for our alpha design, it 
was heavily included in our concept selection process. 
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8.0   THE ALPHA DESIGN  
 
As a result of both the Quantitative and Qualitative Assessments, we selected the Fluid 
Injection Design as our alpha design.  The following section describes, in detail, the alpha 
design of a biopsy needle device with bleeding control that we chose.  The design is fully 
diagrammed in Figure 13 on page 18. 
 
8.1   Device Summary 
 
The alpha design is a biopsy device that deploys a hemostatic plug using a fluid injection 
mechanism after collecting the kidney sample.  The cutting needle and outer cutting 
sheath are plunged into the kidney sequentially, and then retracted out of the cortex.  The 
mechanism used to retract the needle from the kidney also compresses a fluid reservoir 
inside of the handle, expelling fluid down the cutting needle.  At the tip of the cutting 
needle, a pre-loaded Gelfoam® plug is pushed out of the retracting needle and into the 
cavity left in the kidney. 
 
This entire process is triggered by one button on the end of the biopsy device.  The 
collection of tissue and deployment of a hemostatic occur sequentially without extra input 
from the physician using the device.  This was an important aspect of the design, as our 
target for time that the needle was physically inside of the kidney was less than 1 second.  
The BARD® Monopty® design required that the physician remove the needle from the 
patient’s kidney after it had been triggered.  Our design will automatically retract and 
deploy bleeding control, which is safer for the patient and is a simpler procedure for the 
doctor.  
 
8.2   Needle Tip Design 
 
Our alpha design for the needle tip is very similar to the BARD® Monopty® needle, 
except a small tube runs down the length of the inner cutting needle, behind the tissue 
collection groove, and out the front of the tip as seen in Figure 16 on the following page.  
This channel will be plugged at the tip of the needle by the hemostatic agent.  When the 
needle is plunged into the kidney and then retracted with a kidney sample, fluid pressure 
will drive the hemostatic agent out of the tip of the needle and into the biopsy cavity in 
the kidney.  We used the BARD® design as a benchmark because Dr. Weitzel 
recommended it based upon its reliability and frequency of use across the field of 
Nephrology.  Dimensions of this needle will be very small: Dr. Weitzel recommended 
that we constrain the diameter no larger than a 16-gauge needle in order to be widely 
accepted by medical professionals. 
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Figure 16: Needle tip showing channel for hemostatic agent deployment 
 
8.3   Needle-Spring Detachment Mechanism 
 
One novel component of this design is the twisting needle release used on both the 
cutting needle and outer cutting sheath within the handle of the biopsy device as seen in 
Figure 17, below.  A crucial part of this design was having a spring-loaded retracting 
mechanism for the biopsy needles.  Without having an automated retraction of the 
needles, there would be no room in the biopsy cavity for a hemostatic agent to be 
deployed.  The needle and sheath must pull out of the cavity before the hemostatic agent 
is used.  Therefore our design needs to fire a cutting needle and cutting sheath forward, 
detach them from the forward firing mechanism, and then have a mechanism to fire the 
needles backwards and retract them out of the kidney to make room for the hemostatic 
agent.  This critical detaching mechanism is diagrammed and described below. 
 
 
Figure 17: Twisting needle release 
 
Fluid Injection Channel 
Tissue Collection Site 
Team 10   26 
 
This design uses an inner cylinder surrounded by a cylindrical shell to which the needle is 
attached.  The inner cylinder has a small peg extruding perpendicularly outward and 
through a slot in the cylindrical shell.  The inner cylinder is also attached to the spring 
used to deploy the needle. 
 
When the spring is released from a compressed position, it pushes both the cylinder and 
cylindrical shell down the handle of the biopsy device.  Because the cutting needle is 
attached to the top cylinder assembly, and the cutting sheath is attached to the lower 
cylinder assembly, the two are automatically fired sequentially into the kidney.  When the 
cylinder assemblies reach the end of their travel, a helical contour (not shown in Figure) 
along the inside of the biopsy device handle  guides the small peg attached to the inner 
cylinder in an angular fashion, twisting within the outer shell.  The peg spins until it is 
even with the axial slot in the outer shell.  Once this occurs, the outer shell, to which the 
needle is attached, is free to move upwards, as the shell can fit around the entire spring.  
This is the key mechanism to have springs fire the needles forwards and then backwards. 
 
8.4   Fluid Injection System 
 
We decided that a fluid injection system should be used to deploy the hemostatic agent.  
We decided on this mechanism because it would be easy to control the amount of 
material injected into the biopsy cavity.  Also, because of the small nature of the device, 
it would be much simpler than a mechanical pushing mechanism.  A solid plunger would 
be much smaller and more fragile than a fluid system.  A fluid system would be relatively 
simple to assemble during manufacturing.  Lastly, the fluid could be used as an accelerant 
to the rate of expansion of the Gelfoam® in the kidney, rendering it less likely to be 
washed out by excess blood. 
 
The fluid system can be seen in Figure 13 on page 18.  The same spring used to retract 
the cutting needle and sheath is used to compress a small container of fluid.  A tube from 
this container is connected to the end of the hollow channel which runs down the length 
of the cutting needle to the hemostatic plug at the tip.  When the container is compressed 
during retraction of the needles, the fluid pressure causes fluid to be pushed down the 
needle, expelling the hemostatic and a volume of fluid out of the needle tip and into the 
kidney wound caused by tissue removal. 
 
9.0   ENGINEERING PARAMETER ANALYSIS 
 








Figure 18: Model of fluid channel at needle tip 
D
Gelfoam® Fluid Kidney 
Device
L
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For this fluid model, it is safe to assume quasi-static equilibrium (acceleration not 
considered).  This is because our only concern is expelling the Gelfoam® from the tip of 
the device.  For these calculations, the velocity of the fluid is not important to us, so the 










Figure 19: Model of fluid reservoir and fluid channel 
Because we are assuming steady state conditions, the pressure at all points must be equal 
 
      (1) 
 
Where Ft is the total force from the plunger compressing the reservoir, and Fgf is the 
frictional force of the Gelfoam® in the tip of the fluid channel.  Using the relationship for 
area, we get 
 
           (2) 
 
To determine Fgf, we can use the coefficient of static friction, µ, and the average pressure 
of the Gelfoam® plug against the channel wall, Pavg, to get 
 
          (3) 
 
However, because it was too difficult to calculate the average Gelfoam® pressure, and 
we were unable to determine the coefficient of friction of the Gelfoam® against the 
inside of a needle tube, we determined the force needed to expel Gelfoam® from a small 
needle by testing on medical supplies that we had.  For the scope of this project, we felt 
that this was the most efficient way to determine this force. 
 
9.2   Gelfoam® Testing 
 
The pressure needed at the needle tip to push out a Gelfoam® core is the spring force in 
the retraction spring times the area of the fluid reservoir, as given in Equation 1, above.  
In our test, we measured Ft using a 15 mm diameter syringe was 22.5 N.  We plan on 
using a 1 mL syringe in our prototype with a diameter of 7 mm.  Therefore, using 
Equation (1), we determined that the necessary spring force for a syringe this size was 
10.5 N.  This value was below the spring force of the BARD® biopsy device springs, and 
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9.3   Snap Fit Analysis 
 
We decided to use snap fit parts in three components of our design.  The BARD® 
Monopty® device that we used as our primary benchmark used snap fits for the same 
functions as our device, and through studying the effectiveness of this design and further 
research, we have decided that snap fit components are good design choices for our 
biopsy device.  Snap fits decrease the number of parts and greatly decrease the assembly 
time for the device, making it cheaper to manufacture.  Below are the equations 
governing the mechanics of snap fits that we used in the design of our parts. 
 










h = height 
b = base width 
L = length of deflected region 
α = insertion angle 
ε = permissible strain value (42% of yield strain for repeated-use snap fit parts) 
E = young’s modulus 
µ = coefficient of friction between two snap fit parts 
 
Figure 20a:  Snap-fit tooth diagram 
 
Maximum deflection of straight cantilever beam, y 
 
L               (4) 
 
Deflection force, P 
                (5) 
 




     (6) 
 
Because several assumptions need to be made before this analysis can be done, the best 
method for designing a snap fit part is to use excel to keep track of all of the variables.  
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Figure 20b: Loaded spring being held in place by snap fit teeth 
 
This is the upper spring, which is used to fire the inner collection needle into the kidney.  
To cock this spring to prepare for deployment, it is first compressed by having an 
assembler raise the cylinder (in white at the bottom of Figure 20b) that it is resting on.  
When the snap fit mechanism reaches the opening at the top of the chamber, the teeth are 
forced inwards because of their outer slope.  The displacement is purely elastic, as the 
teeth and cylinder are all one piece.  Once they have been pushed through this opening, 
the elastic energy of the material forces the teeth to snap outwards, and they rest on the 
top side edges.  Once they are resting in this position, the spring is fully compressed and 
ready to deploy, as the teeth provide an equal and opposite force to keep the spring 
compressed.  To fire the spring, the button (directly above the teeth) is depressed.  The 
triangular cut in the bottom the button forces the teeth to deflect inwards and off of the 
edge of the opening.  Once they have been forced inwards, the spring is free to fire, and 
the entire assembly is forced downwards by the elastic energy in the compressed spring. 
 
The second spring and the spring of the retraction mechanism both use a compliant 
mechanism in the same way.  Using compliant teeth to hold a compressed spring is very 
effective because it requires few parts and a relatively low activation force to operate.  
However, it was critical to calculate this activation force, because it would be applied by 
other springs.  Therefore, the force was prescribed, and the design needed to have an 
insertion (non-inward) force requirement that was less than the spring force.  To ensure 
this, we used a spreadsheet to perform iterations of geometry and material properties to 
find the optimal combination to give a minimum required insertion force.  The critical 
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rows are shown below in Table 4.  For the entire table of geometrical values of the 
compliant teeth, see Appendix C. 
 








deflect force, P (N) 4.586 4.586 5.732 
insert force, Fi (N) 6.213 6.213 6.526 
Force to release mechanism 
(N) 12.43 12.43 13.05 
 
Table 4: Force to release compliant teeth in biopsy device 
 
The crucial row of this table is “Force to release mechanism.”  This is the total force 
needed to cause the teeth to be deflected the necessary distance to release the compliant 
mechanism.  The typical thumb force a human is able to apply is 133-191 N [8], well 
above the release force values we calculated.  Therefore, the only concern was to make 
the force below the spring force of our chosen springs. 
 
9.4   Spring Force Measurements 
 
To simplify the design process, we decided to use spring forces similar to the BARD® 
Monopty® biopsy device.  This was a good benchmark to use because, as Dr. Weitzel 
informed us, it was widely accepted as a good device for kidney biopsies (if patient 
bleeding is not a concern).  Therefore, we could safely assume that the springs in the 
device were strong enough to penetrate the cortex of the kidney.  With the help of Jason 
Moore and the prostate biopsy project team in the Wu Manufacturing center, we used a 
Kistler© load cell to measure the force of the springs when fully loaded and at the end of 
the 22mm stroke into the kidney.  At the fully compressed length, the spring force is 
14.67 N, and at the extended length, the force is 9.32 N.  The averaged values from each 
trial are seen below, in Table 5. 
 
  Compression to 19 mm total spring length 
  Spring 1 Spring 2 
Run 1 2 3 1 2 3 
avg value 
(N) 15.48 16.11 14.79 13.57 12.78 15.32 
  Total average (N) 14.67   
Table 5: The average spring force from all trials is 14.67 N 
 
From Table 4, the force to release the mechanism is only 12.42 N, which is below the 
measured spring force in Table 5.  This was a critical requirement for our design, as it 
cannot function if the springs are not strong enough to deploy the next stages in the 
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biopsy device mechanism.  Therefore, we will be using 13 mm diameter springs that have 
a 50 mm rest length, and 9 coils.  These are the same dimensions as the BARD® design, 
but we have proven that they will work for our design.  We will use 3 of these springs. 
 
9.5   Kidney Insertion Force Measurements/Needle Analysis 
 
In order to understand the forces needed to insert a needle into the cortex of the kidney, 
we met with Dr. Rao in the Nephrology department at the U of M health system to 
discuss kidney models.  Before the meeting, we made several blocks of biogel, the 
material used by the kidney biopsy team at the Wu Manufacturing center to model human 
organs.  We made blocks of several stiffnesses to present to Dr. Rao for comparison.  We 
did this because although through research, we determined that typical kidney has a 
density of 1050 kg/m3 and a Young’s modulus of 1.2 MPa [9], we had no reliable way to 
measure either of those quantities within the scope of our project. 
 
After biopsying all of our biogel blocks, Dr. Rao selected which was the most similar to a 
human kidney.  He also recommended biopsying a normal red apple as it is very similar 
to a kidney.  We used both an apple and our biogel in our biopsy force tests.  To perform 
these tests, we placed the tip of the BARD® Monopty® needle to the surface of the 
kidney material and biopsied it while it was resting in a force transducer.  This measured 
the compressive force applied through the needle during operation. 
 
The biogel data resulted in a maximum insertion force of 3.175 N.  Because Dr. Weitzel 
strongly recommended that we use a 16-gauge needle for our design, we will assume a 
solid cylindrical needle with a diameter of 1.65 mm.  Using the following equation 
 
       (7) 
 
Where σ is the normal stress of the needle, σ = 1.48 MPa.  Therefore, the material chosen 
for our needle must have a yield strength of at least 1.48 MPa.  Applying a factor of 
safety of 1.5, the yield strength should be, at minimum, 2.23 MPa. 
 
9.6   Fluid Volume Calculation 
 
Because the device needs to expel enough fluid to push the Gelfoam® core out of the tip 
of the needle, we calculated exactly how much fluid the system should expel to be 
effective.  It was important to inject enough to get the Gelfoam® out of the device, but 
also not too much, as this would be wasteful and cause fluid to spill after the tissue 
sample was removed. 
 
We decided that the volume of the hole created by the needle within the kidney should be 
equal to the amount of fluid that is driven forward by the fluid plunger mechanism.  This 
way it is guaranteed that the cavity in the kidney will be completely filled by Gelfoam® 
and fluid.  Assuming a 22 mm needle plunge depth and a needle diameter of 1.65 mm, 
the fluid volume equal to the volume of the needle that is fired into the kidney is 0.047 
mL.   
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Also important to the fluid system of the device is the total fluid volume throughout the 
system.  To determine this value, we calculated the volume of the three major 
components of the device: the fluid reservoir, the tube from the reservoir to the needle, 
and the needle.  To see the table of values for each of these components, see Appendix D.  
The total volume of the system that we calculated is 0.528 mL. 
 
Because this value is very different than the volume of fluid that needs to be injected into 
the cavity left by the biopsy, two hydraulic devices will need to be used in the loading of 
our device.  One will be used to fill the system with fluid, and the other will be used 
during the operation of the device to push fluid through the system and out the tip of the 
channel at the distal end of the needle.  For the prototype, we will be using syringes, as it 
will be easy to order them and assemble them into our device.  To fill the needle and 
tubing with fluid, a large syringe will be attached to the tubing attached to the needle.  
When the needle tip is submerged into the fluid solution and the plunger is drawn back, 
the system will fill with fluid.  Once this has been done, the large syringe will be 
removed, and a smaller diameter, prefilled syringe will be attached to the tube and loaded 
into the retracting mechanism.  The smaller diameter syringe will inject the correct 
amount of fluid when used with a 22mm stroke.  However, it does not have the volume to 
fill the entire fluid system in preparation for the biopsy.  The larger diameter syringe will 
be used for this function. 
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10.0   FINAL DESIGN DESCRIPTION 
 
10.1   Device Overview and Component List 
 
Our final design was based on the engineering design parameter analysis as discussed 
above, and can be seen in its entirety in Figures 21 and 22. 
 
 
Figure 21:  Fully assembled final design  
 
 
Figure 22:  Final design shown with internal detail 
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The parts and components used in this device can be seen in Figure 23, with descriptions 




Figure 23:  Exploded view of device 
 
Part Label Description
A Upper half of housing
B Lower half of housing
C Deployment button
D Inner collection needle outer cylinder push rod slider button
E Inner collection needle outer cylinder push rod
F Deployment spring
G Inner cylinder/Spring disengagement cylinder
H Inner collection needle outer cylinder 
I Inner collection needle
J Outer cutting sheath outer cylinder
K Outer cutting sheath




P Needle retract/hyrdraulic plunger compress mechanism
Q Push plate
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10.2   Device Description 
 
Tissue collection with this device is initiated by pressing the deployment button on the 
top of the cylindrical handle.  This deployment button triggers a sequence of actions 
within the device that function to collect tissue and deposit Gelfoam® to control bleeding 
at the collection site.  The deployment button consists of a triangular notch in the bottom 
which triggers the first action in the sequence by releasing a spring loaded compliant 
mechanism.  This release causes a spring to propel an inner cylinder surrounded by an 
outer cylinder with an attached needle, resulting in the attached needle plunging into the 
kidney tissue to a depth of 22 millimeters.  This attached needle is called the inner 
collection needle, and consists of a sharpened tip, a tissue collection site, and a Gelfoam® 
injection channel which will be discussed later.  The inner and outer cylinders are locked 
together by a peg that is attached to the inner cylinder and sits in a slot in the outer 
cylinder.  While the cylinders travel down the device, a helical track on the inside of the 
top half of the housing guides the peg around the slot to disengage the two cylinders.  The 
purpose of this disengagement will be discussed later.  In addition, a push rod that is 
attached to the outer cylinder and works in conjunction with the disengagement 
mechanism is propelled down the device by the motion of the outer cylinder.  Figures 24, 
25, and 26 show these described motions in detail.   
 
 
Figure 24:  When button is pressed, compliant teeth of inner cylinder are compressed 
together 
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Figure 25:  Position of internal components in first action of sequence 
 
 
Figure 26:  Inner collection needle in first position of sequence 
 
The second action in the sequence is triggered by the inner cylinder that moved in the 
first action of the sequence.  This cylinder has a conical notch on the end opposite the 
composite teeth that acts like the triangular notch on the deployment button.  When this 
inner cylinder reaches its full travel stroke, the conical feature compresses a set of 
compliant teeth on the second cylinder and triggers an action very similar to the first.  
The second cylinder and corresponding cylindrical shell with attached needle and push 
rod travel 22 millimeters, as in the first action.  The needle attached to this second outer 
cylinder is hollow, and is called the outer cutting sheath.  This needle cuts tissue during 
its travel, and holds the tissue sample in the sample collection site on the inner collection 
needle.  Figures 27, 28, and 29 show the motions of the second action in the sequence in 
detail. 
 
Tissue collection site 
Gelfoam® injection channel 
Button depressed 
Helical guide 
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Figure 27:  First cylinders positioned just before reaching full length of travel 
 
 
Figure 28:  Position of internal components in second action of sequence 
 
 
Figure 29:  Outer cutting sheath extended over inner collection needle 
 
The final action in the sequence results in the retraction of the needles from kidney tissue, 
while simultaneously depositing Gelfoam® into the tissue cavity left behind.  When the 
second inner cylinder reaches its full length of travel, its attached push rod triggers a set 
of compliant teeth, releasing a spring-loaded push plate (see Figure 30).  When this plate 
2nd Helical 
guide on inside 
of housing 
2nd inner cylinder 
disengaged from 2nd 
outer cylinder 




Outer cutting sheath 
Sealed collection site 
Fluid Injection Channel 
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is released, the spring propels the plate and pushes on the push rods attached to both outer 
cylinders.  Since both inner cylinders have been disengaged from the outer cylinders by 
the helical guides, the outer cylinders are free to slide back up the device and pull the 
needles out of out of the kidney tissue.  In addition, this push plate serves to compress a 
fluid plunger into a syringe-like fluid chamber.  The syringe-like device is connected by 
tubing to the end of the inner collection needle, which features a hollow channel for fluid 
injection purposes (see Figure 29).  A pre-loaded amount of Gelfoam® is located in the 
tip of the Gelfoam® injection channel of the inner collection needle, and the remainder of 
the channel, connective tubing, and the fluid chamber is filled with saline solution.  When 
the needles are retracted, the plunger of the syringe-like device is compressed, injecting 
the Gelfoam® out of the end of the inner collection needle and into the tissue sample 
cavity.  Figures 30-33 show the motions of this third action and final positions in detail. 
 
 
Figure 30:  Second cylinder positioned just before reaching full length of travel 
 
 
Figure 31:  Position of internal components at end of sequence 
Fluid plunger 
1st outer cylinder push rod 
2nd outer cylinder push rod 
Push plate 
Needles and outer 
cylinders retracted 
Spring extended 
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Figure 32:  Position of internal components at end of sequence 
 
 
Figure 33:  Flexible fluid tubing connecting syringe-like device to inner collection needle 
 
Once the sequence of events has completed, the doctor can remove the tissue sample 
from the device by using an external slider.  This external slider is attached to the push 
rod of the first outer cylinder.  By moving the external slider, the push rod compresses the 
retraction spring and allows the inner collection needle to slide out from inside of the 
outer cutting sheath and expose the tissue collection site.  This can be seen in Figure 34. 
 
 






Push slide Push slide slid forward 
Inner needle pushed out 
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10.3   How Gelfoam® Works 
 
Gelfoam® (a Pfizer™ product) is a hemostatic agent fabricated from absorbable pig skin 
gelatin and can come in two forms, an absorbable gelatin compressed sponge and an 
absorbable gelatin powder.  Gelfoam® is placed within the wound and prevents excessive 
bleeding by acting as both a physical obstruction to blood flow and acting as a lattice for 
blood clot formation.  It is able to hold up to 45 times its weight in blood.  When placed 
in soft tissue, Gelfoam® liquefies within a week and completely dissolves in 4-6 weeks 
[11]. 
 
The absorbable gelatin powder is created by milling and sterilizing the compressed 
sponge into a fine powder.  The powder is then combined with saline solution to form a 
thick paste.  Compressed sponge Gelfoam® is to also be pre-saturated with saline 
solution.  Details on Gelfoam® preparation can be found in Appendix G. 
 
Our device will eject a saline-saturated compressed sponge of Gelfoam® into the tissue 
removal site.  After the ejection channel and fluid tubing of our device have been pre-
loaded with sterile saline solution as described in the Engineering Design Parameter 
Analysis, Gelfoam® will be prepared as described in Appendix G and manually loaded 
into the tip of the ejection needle.  The saline solution will be compressed by the fluid 
ejection mechanism within our device, generating enough pressure (as determined in the 
Fluid Pressure Requirements section of the Engineering Design Parameter Analysis) to 
drive the Gelfoam® out of the needle and into the kidney. 
 
11.0   INITIAL MANUFACTURING PLAN AND MATERIAL 
SELECTION 
 
To start our manufacturing plan, we looked at the function of each component and 
generated material property requirements (see Engineering Parameter Analysis section), 
and developed a feasible manufacturing approach for each. 
To categorize our parts, we formed groups of components with similar manufacturing 
processes.  We will further discuss the reasoning behind each grouping in the individual 
component breakdowns. We also noted the mechanical properties of many materials to 
help us in the proper selection. Our components are broken into the following categories: 
plastic parts, the needle, fluid deployment assembly, pushrods, and springs. Tables 7 and 
8 summarize our chosen manufacturing processes, materials, and estimated costs for 




MATERIAL UNIT COST 
Housing Injection Molding Delrin $1.03-$1.13 per lb. 
Outer Cylinder (2) Injection Molding Delrin $1.03-$1.13 per lb. 
Inner Cylinder (2) Injection Molding  Delrin $1.03-$1.13 per lb. 
Retraction Plate Injection Molding Delrin $1.03-$1.13 per lb. 
RetractionMechanism Injection Molding Delrin $1.03-$1.13 per lb. 
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Pushrods (2) Injection Molding Delrin $1.03-$1.13 per lb. 
Buttons (2) Injection Molding Delrin $1.03-$1.13 per lb. 
Cutting Sheath Extrusion Type 304 Stainless 
Steel 
$2.50-$3.50 per lb. 
Inner Needle Extrusion and Milling Type 304 Stainless 
Steel 
$2.50-$3.50 per lb. 
Syringe Injection Mold Delrin $1.03-$1.13 per lb. 
Fluid Mechanism 
Tubing 
Purchase Clear PVC Tubing $0.13 per foot 
Springs Purchase Type 302 Stainless 
Steel 
$2.93-$3.23 per lb. 




MATERIAL COST AND PROVIDER 
Housing (2 halves) FDM ABS Plastic $88 from UM 3D Printing Lab
Outer Cylinders (2) FDM ABS Plastic $64 from UM 3D Printing Lab
Inner Cylinders (2) FDM ABS Plastic $64 from UM 3D Printing Lab 




Mill PVC Received from Bob Coury 
Retraction Platform FDM  ABS Plastic $64 from UM 3D Printing Lab 




FDM ABS Plastic $64 from UM 3D Printing Lab 
(Same Print as Outer 
Cylinder) 
Buttons (2) FDM  ABS Plastic $64 from UM 3D Printing Lab 
(Same Print as Outer 
Cylinder) 
Pushrods Hand Forming (Pliers)  Type 304 
Stainless Steel
$2.20 from McMaster Carr 
Cutting Sheath Band Saw, Dremel Type 304 
Stainless Steel
$19.41 from McMaster Carr 




$19.28 from McMaster Carr 
Syringe Purchase Plastic Received from Dr. Weitzel 
Fluid Mechanism 
Tubing 
Purchase Clear PVC 
Tubing 
$4.25 from McMaster Carr 
Springs Purchase Type 302 
Stainless Steel
$3.99 from Home Depot 
Table 7:  Bill of materials for prototype 
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In the following sections we will describe each component, broken down by material.  
Further specifications on their precise dimensions can be found in Appendix E. 
 
11.1   Plastics 
 
The majority of components in our handle mechanism will be manufactured out of 
plastic; specifically, medical grade Delrin. The parts included in this category are the 
outer housing, the outer cylinders, the inner cylinders with compliant release 
mechanisms, the pushrods, button, retraction plate and retraction compliant release 
mechanism, syringe, and tubing used to connect the syringe to the needle. 
 
11.1.1   Material Selection 
 
To begin we gathered as much information as we could from other sources as to what 
would work the best for these plastic components. We began by benchmarking current 
devices and investigated commonly used materials used in the medical field today. The 
most obvious benchmark was the BARD® MONOPTY® kidney biopsy.  The plastic 
components of the BARD® device are constructed out of a Vinyl PVC 
(Polyvinylchloride) that easily withstands forces, including the spring forces and the 
bending of the compliant release mechanisms.  We also spoke with Phil Wong about  
potential materials, with his recommendation being a material similar to Vinyl PVC 
called Delrin (Polyoxymethylene).  
 
The physical properties of both Vinyl PVC and Delrin are diagrammed in Figure 35, 
below.  We used CES Edupack software [11] to generate this plot and organize material 
property data.  In generating this plot we considered important physical properties that 
would affect the performance of our design, such as density, young’s modulus, and 
percent elongation. Cross referencing these two materials with all other materials only 
provided one other viable material option, PET (Polyethylene terephthalate). 
 
 
Figure 35: Density versus Young’s Modulus for Materials Similar to PVC and Delrin 
 
Density (lb/ft^3)






















Polyoxymethylene (Acetal, POM) 
Polyethylene terephthalate (PET)
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Each of these materials could satisfy most of the requirements of our design.  To 
determine a frontrunner, however, we considered our engineering design parameter 
analysis. To make this manufacturing process simpler, we decided to use the same type of 
plastic for all components. Therefore we found the components that were (a) subjected to 
the highest stresses and (b) required the most elasticity in order to determine the limiting 
material properties of the plastics within our device.  Based on our analyses, one part 
satisfies both (a) and (b):  the compliant snap fit mechanism. This part is both subjected 
to a high force and requires bending.  Therefore it must be made from a material which is 
strong enough to prevent breaking, but also has a Young’s modulus low enough to permit 
deflection. This is further examined in Appendix C.  
 
The Yield Strength and Tensile Stress of the Delrin plastic are higher than that of the 
other two plastics, and Delrin is also strong enough to withstand the calculated forces that 
will be encountered during release.  In Table 8, the Young’s Modulus and Yield Stress to 
Ultimate Strength values of Delrin Plastic are compared with values determined by the 
equations in Appendix C. The values of Delrin satisfy values determined through analysis 
of the snap fit mechanism; therefore, we chose to manufacture all plastic components out 
of Delrin. 
 
 Young’s Modulus Strength 
Delrin Plastic 5 GPa 72 MPa – Yield Strength 
90 MPa – Ultimate Strength 
SNAP FIT equation numbers 3 GPa 80 MPa – Yield Strength 
Table 8:  Selected material and required properties [11] 
 
Details on the manufacturing of each plastic component can be found in the following 
sections. 
 
11.1.2   Housing 
 
The housing is the largest component of our device and requires the greatest amount of 
material (see Figures 36 and 37).  We looked at its many complexities to determine the 
best manufacturing process. 
Mass Production 
 
The housing is two-piece item that could be injection molded.  Because it is a plastic 
component and has a complex geometry, injection molding is the manufacturing process 
of choice for mass production. 
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Figure 36: Handle Mechanism Housing – Side 1 
 
 





Injection molding is not a viable option for our prototype due to budget and time 
constraints.  Therefore we considered two main options for manufacturing our prototype 
housing: milling or 3-D printing by a Fused Deposition Modeler (FDM).  The FDM 
process reads the part file of a CAD drawing and dispenses molten polymer through a 
nozzle to build the part layer by layer.  We researched both options and also sought 
advice from Phil Wong of MC3 Manufacturing.  We very quickly found disadvantages 
for the milling process and advantages for the FDM process. One disadvantage of the 
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milling process is that we would be working with round stock, which can be hard to 
secure within a mill. Another disadvantage of milling is due to the level of complexity 
and detail within the housing, which would require a complex tool path.  The FDM 
process, on the other hand, allows for a great amount of detail and requires much less 
labor time than the milling process.  We concluded that the best way to manufacture this 
part is by 3-D FDM printing.  This decision was also approved by Phil Wong of MC3. 
 
11.1.3   Inner and Outer Cylinders 
 
Mass Production  
 
In mass production, the inner and outer cylinders (see Figures 38 and 39) would also be 
manufactured through injection molding, allowing for precise and consistent dimensions 
and rapid production. 
 
   




The method of prototype manufacturing for both the two inner and the two outer 
cylinders was also by 3-D FDM Printing, with slight modifications: 
• The hole for the needle (see “A” in Figure 39, above) was manually drilled.  The 
needle (either cutting sheath or inner needle) will be glued within this hole, and 
the retraction mechanism pushrods will be glued to the opposite side of the outer 
cylinder. 
• The compliant release ‘teeth’ of the inner cylinders were manufactured separately 
due to the high forces and bending stresses they must be able to withstand (recall 
reasoning from the Materials Selection section).  These teeth were hand milled 
from PVC stock and glued into a socket-like inner cylinder, which featured two 
slots just for this purpose.  
 
A
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11.1.4   Retraction Mechanism 
 
The plastic components of the retraction mechanism consist of the Retraction Release 








For our prototype, both of these components were generated by the 3-D FDM printing. 
 
  
Figures 40 and 41: Retraction Release Mechanism and Retraction Plate 
       




The deployment button and collection sample retrieval button (see Figures 42 and 43, 
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Figures 42 and 43: Deployment Button And Collection Sample Retrieval Button 
 




Both retraction pushrods (for upper and lower outer cylinders) are to be injection molded 




In the manufacturing of our prototype pushrods acquired some round metal stock and 
form it into the shape we needed for our uses. The first pushrod, which is longer and 
connected to the inner collection needle cylinder, required one bend.  The second 
pushrod, which is connected to the cylinder of the outer cutting sheath, required two 
pieces of metal which were then soldered together. 
 
 
Figure 44: Inner collection needle pushrod 
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Figure 45: Outer cutting pushrod 
 
11.2   Stainless Steel Components 
 
The major stainless steel components of our design are the cutting sheath and the inner 
collection needle.  
 
11.2.1   Material Selection 
 
From consultation with Dr. Weitzel and analysis of current medical devices, we knew the 
needle components would need to be made from medical grade stainless steel or a similar 
material.  From this conclusion and results of our engineering parameter analysis of the 
stress in the biopsy needle, we found that one acceptable material was type 304 Stainless 
Steel. Once we again we took this information and used CES Edupack [11] to compare 
other materials. We used values of the type 304 Stainless Steel and obtained the results 
shown in Figure 46. We further researched more specific Stainless Steels and found other 
materials with similar physical properties. All options are presented in Figure 47. 
 
 
Figure 46: CES Edupack [11] Material Comparison 
Density (lb/ft^3)





























Figure 47: CES Edupack [11] Material Comparison 
 
From these possibilities, we selected a medical grade type 304 Stainless Steel due to its 
current acceptance in the medical industry.  This material has been proven in biomedical 
applications. 
 
11.2.2   Inner Needle 
 
Our needle design was based off the current biopsy device, but features and internal 
channel for Gelfoam® deployment into the kidney. The size, shape, and dimensions are 
virtually the same except for this new channel. This new channel will affect our design, 
however, due to the fact that structural integrity is compromised.  See Figure 48 for a 




To mass produce the inner collection needle, we propose using hot metal extrusion.  In 
the hot metal extrusion, liquid metal will be pushed through a die in order to make a piece 
with the same cross section as the die.  Because of the long prismatic nature of the 
needle, this process is ideal for mass production.  A die would be need to made into the 
same shape as the cross section of the needle, and type 304 Stainless Steel would be 
pushed through it to form a very long section of needle.  It would be cut into needle-sized 





The manufacturing of the inner needle is the most difficult piece to complete for our 
prototype. We spoke many times with Dr. Weitzel and Phil Wong to see what their best 
Density (lb/ft^3)
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ideas were for manufacturing. The channel which will be delegated to deploy the 
Gelfoam® was too small to manufacture from a solid rod. There was also the difficulty of 
creating this feature underneath the tissue collection site. Therefore we had to look for 
another method of manufacturing.  
 
What we came up with for our inner needle was to first obtain a hollow needle that will 
fit inside of our cutting sheath. Once we had this hollow needle, we would cut an 
indentation the size of the tissue collection site using a wire EDM. Once this hole was 
created, we would use a small piece of wire to make a separation between the tissue 
collection site and the Gelfoam® deployment channel. We would then pour epoxy into 
the tissue collection site and hand form it into the correct shape. Once this is done we 
would be able to remove the wire or shim and we will have effectively created both the 
tissue collection site and the Gelfoam® deployment channel. 
 
This plan was not effective, however, because we were unable to create a thin enough 
barrier between the tissue collection site and ejection channel.  We therefore used a 
second method of prototype fabrication: we heated the steel, then pressing a collection 
site into the distal end of the needle.  In this way we were able to depress the material into 
a collection site, although it was much shallower than designed.  Research into a more 
effective inner needle manufacturing process is recommended. 
 
 
Figure 48: Inner Collection Needle With Gelfoam® Deployment Channel 
 




For manufacturing the cutting sheath, we recommend a hot extrusion method.  This metal 
would then have to be treated to make sure it was compatible in a biomedical setting. 
Also, a wire EDM cutting operation is recommended in order to create the sharp tip of 
the needle so that it will penetrate the kidney cortex and tissue. 
 
  




For our prototype, we purchased a 16-gauge hollow needle.  We then used a mill to cut 
this needle to the appropriate length, and to create the sharp tip. 
 
 
Figure 49: Outer Cutting Sheath 
 
11.3   Other Materials: Hydraulic Mechanism 
 
The components of the hydraulic mechanism consist of the fluid chamber, plunger, and 
connective tubing, which are manufactured from various materials.  See Figures 50, 51, 




The material for the hydraulic mechanism consists of Delrin plastic for the hydraulic 
chamber and syringe and flexible PVC tubing for the connective tubing.  See section 
11.1, Plastic Components, for further information on Delrin plastic and the reasoning 
behind its selection as a material within our device.  Flexible PVC tubing was selected for 




In a mass production situation, the fluid chamber part would be integrated into the 
housing design. Therefore when the two sides of the housing are closed together, the fluid 
reservoir is created. The plunger would be placed in the fluid reservoir as it was closed 
together, creating a sealed system.  The plunger itself could be injection molded from 




These components vary greatly from the rest of the design because this entire piece was 
purchased for our prototyping purposes. We used a modified 10 mL medical syringe and 
flexible PVC tubing for our hydraulic system.  We secured the system by gluing the 
syringe to the housing, which has a spot delegated for this in its design. 
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Figure 50: Plunger 
 
 
Figure 51: Syringe Tube 
 
 
Figure 52: Tubing 
 
11.4   Other Materials: Springs 
 





We decided to use type 302 Stainless Steel for our springs.  After researching multiple 
suppliers online such as McMaster-Carr and Home Depot, we found this spring material 
to be common and inexpensive.  The wide variety of spring sizes and rates with this 




For our prototype, we will be purchasing springs from McMaster-Carr.  For mass 
production, we would also recommend using a third party supplier.  Buying a large 
number of springs from a third party will be more cost efficient than investing in 
machines to make springs to our specifications. 
 
  




The springs that we will be using for our prototype will be purchased, and their size, 
shape, and spring force will be based off the previously determined values from the 
BARD® Monopty® device. These have proven that they can be strong enough to 
penetrate the kidney, which is most important in picking the springs. 
 
12.0   DESIGN FOR THE ENVIRONMENT 
 
12.1   Environmental Impact 
 
The environmental impact of our design was analyzed through SimaPro, a software 
package designed to determine the amount of raw materials, air, water, and waste 
associated with the design.  The analysis was based off of the type 304 stainless steel 
used for our device needles, and the Delrin plastic used for our housing and internal 
components.  A similar material, injection-molded PVC, was substituted for Delrin in this 
analysis as Delrin is not available in SimaPro.  By these calculations, each one of our 
devices (not including packaging or shipping materials) would use approximately 15 kg 
of raw material, affect 351 g of air, affect 18 g of water, and produce 47 g of waste.  
Graphs showing the values associated with each material can be seen below. 
           
Figure 53:  Amount affected by stainless steel used in one of our devices 
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Figure 54:  Amount affected by plastic used in one of our devices 
 
Figure 55:  Relative point levels for effects by stainless steel in one device 
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Figure 56:  Relative point levels for effects by plastic used in one device 
 
13.0   FAILURE/SAFETY ANALYSIS 
 
Because our device will be used in medical applications, safety is of critical importance.  
To ensure the risks of our device to the user population have been addressed, we have 
generated a Failure Mode and Effect Analysis (FMEA) using DesignSafe software.  The 
complete report, which includes potential failure modes and proposed solutions, can be 
found in Appendix H.  We have identified three major classes of potential safety hazards 
and failure modes: Contamination, hydraulic system failure, and mechanical system 
failure, which are described in further detail below. 
1. Contamination:  Contamination of the device (especially the needle), the 
hemostatic agent, or the hydraulic fluid (e.g. saline solution) may lead to infection 
in the biopsy patient.  Careful consideration must be given in the following areas 
to prevent contamination: 
a. Manufacturing/Assembly:  Manufacturing and assembly of the needle and 
hemostat system must be performed in a sterile environment. 
b. Shipping/Storage:  Reliable medical grade sterile packaging must be used 
to prevent contamination during shipment and storage.  Additionally, a 
shelf life rating for the device (especially for the hemostat and fluid 
system, which may be prone to bacteria or mold) must be determined and 
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c. Operation:  The biopsy, as is standard procedure today, must be performed 
under sterile conditions. 
d. Post-use:  Post-biopsy device is a biohazard and must be properly 
disposed by the operator. 
2. Hydraulic system failure:  Hydraulic system failure is of concern because it would 
likely mean the hemostat has not been effectively deployed into the kidney, 
therefore rendering our device useless at preventing excessive bleeding. 
a. Leakage:  Leakage within the hydraulic system would cause a loss of 
pressure and failure to deploy the hemostat into the kidney.  Emphasis 
must be placed on precision of hydraulic system assembly to ensure no 
leakage and component interfaces. 
b. Rupture:  Rupture of the system may occur due to a ‘clog’ or excessive 
kidney backpressure due to variation of operator technique (i.e. moving 
the device deeper into the kidney during hemostat deployment).  Emphasis 
on a debris-free interior, standardization of hemostat insert, and doctor 
operation standardization would all reduce the risk of hydraulic system 
rupture. 
3. Mechanical system failure:  Mechanical system failure would mean the 
functionality of the device has been compromised.  This is of critical concern 
because mechanical failure may result in some, or all of the following problems: 
injury to patient or doctor; insufficient tissue sample size; ineffective anti-
bleeding control.  All of these problems are unacceptable. 
a. Fatigue failure:  Our device features many small, moving parts.  The 
current industry standard is a repetition of three uses per device.  
Therefore, a fatigue failure test must be performed to ensure the device 
will not fatigue prior to intended lifetime.  If the device is made reusable, 
the fatigue failure lifetime must be substantially greater, with strict 
controls in place to discard devices once they have reached their fatigue 
lifetime (reduced, of course, by a sufficient factor of safety).  Critical 
components which may fatigue are all three compliant release mechanisms 
(‘snap locks’) and the rotating cylinders, “teeth” and corresponding guide, 
though the entire system must be tested to determine the weakest 
component. 
b. Misalignment failure:  Misalignment of the moving parts of our system 
would prevent proper functionality of our device.  A precise, standardized 
assembly system and device inspection strategy must be developed to 
ensure correct alignment. 
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14.0   FINAL PROTOTYPE 
 
Our complete assembled prototype is shown below. 
 
 
Figure 57: The final prototype 
 
14.1   Changes from Final Design 
 
Our prototype held very true to our final design. Our CAD drawings represented almost 
exactly what we produced. 
The main differences of our prototype were two steel guides on the retraction mechanism 
and the inner cylinder. The two guides were added to assist in maintaining the straight 
path of the retraction spring and prevent excessive deflection, a problem noted during 
preliminary trials.  These served the purpose of maintaining the spring’s alignment and 
intended path of travel, and were added when we realized the reaction force of all three 
items to be retracted (lower cylinder push rod, upper cylinder push rod, and fluid 
chamber) was causing the retraction spring and push plate to bend out of alignment.  
Consequently, without the addition of the guide rods, the retraction mechanism failed.  
See Figure 57 for the additional guide rods. 
 
The other main difference was the inner cylinder. The compliant mechanism was not 
working correctly with the original inner cylinder as the ABS plastic teeth (the material 
used in 3-D FDM printing) were breaking. Therefore we changed the design of the inner 
Guide Rods along 
Retraction 
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cylinder to have sockets for new teeth we created with the stronger Delrin plastic. These 
teeth were glued into the sockets, solving the problem. The inner cylinder was no 
different than the CAD drawing of the inner cylinder, but was produced in a different 
fashion than we had previously determined.  This adjustment was necessary as 
components printed on the FDM machine were not as strong as the Delrin plastic, the 
material of intended use. 
 
Our final design only changed with the addition of the guides and the change in the 
prototype material of the inner cylinder.  With these minor adjustments our prototype was 
not affected and we were very successful in designing almost exactly what we had 
designed. 
 
14.2   Test Results 
 
We performed several tests with our protoytype device in order to validate that it 
functioned as designed.  We began testing by performing a mock biopsy on an apple, a 
general test of our fluid injection system, and a test for proper Gelfoam deployment.  We 
determined that all features of the design were demonstrated by our device, but that some 
of the features did not work together due to deviations from the final design that were 
made in the prototype. 
 
14.2.1   Apple Biopsy 
 
We performed our first apple biopsy using the same method as described to us by Dr. 
Weitzel and Dr. Rao.  We held the needle tip just outside the skin of the apple and 
pressed the release button to deploy the device.  In this test, the device was assembled 
with the fluid injection system disengaged so that we could validate the retraction system 
only.  In repeated tests, we determined that our device was capable of sequentially 
deploying the inner and outer needles, and retracting them out of the tissue 
simultaneoulsy.  Figure 58 displays one of our successful test runs.   
 
 
         
Figure 58:  Mock biopsy performed on an apple with prototype device 
 
14.2.2   Fluid Injection System Test 
 
In order to test our fluid injection system, we deployed the device without allowing the 
needles to travel into tissue.  By not using tissue, we were able to better tell whether or 
not fluid was actually being ejected from the needle tip.  Through this test, we determined 
Before deployment Inner needle deployed Needles retracted 
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that our device is capable of ejecting fluid as can be seen in Figure 59.  We also 
determined that due to deviations that were made in our prototype from our final design, 
the hydraulic chamber could not be fully compressed.  This was a result of using an 
oversized cylinder and mounting it to the upper half of the housing rather than the lower 
half as specified in the design.  This resulted in the plunger being offset on our retraction 
mechanism plate, which created a torque and caused the retraction spring to bend during 
its travel.  This problem was partially corrected by the addition of guides (see section 





Figure 59:  Test of fluid injection system on prototype device 
 
14.2.3   Gelfoam Deployment Test 
 
In order to prove that Gelfoam could be ejected from our needle via fluid injection, we 
loaded our device with fluid and the inner needle tip with Gelfoam.  We manually 
depressed the hydraulic cylinder plunger for this test, but immediately found that our 
tissue collection site of our inner needle was not properly sealed, which resulted in a fluid 
leak and loss of pressure.  This improper seal was a result of the manufacturing method 
that we had to use to create the collection site, and was unable to be fixed due to our 
limited manufacturing capabilities.  From here, we decided to use a similarly sized needle 
to eject Gelfoam from our device, which would validate our design with the assumption 
that a proper manufacturing method would be used in actual production of our device.  
Though this test, we were able to eject Gelfoam via fluid injection into a mass of biogel.  
This can be seen in Figure 60. 
 
 
Figure 60:  Gelfoam deposited in biogel sample 
Gelfoam 
Before deployment After deployment 
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14.2.4   Overall Device Performance 
 
Our prototype demonstrated that our design for needle retraction, fluid injection, and 
Gelfoam placement all would work in a mass produced device.  Although we had some 
difficulty with interaction between the retraction mechanism and the hydraulic cylinder 
plunger, we are confident that the problems would be solved if the device was built to 
design specifications with a properly sized and placed hydraulic cylinder.  With proper 
manufacturing techniques for the inner collection needle that allow for a liquid-tight seal 
through the entire fluid ejection channel, there would be no issue with pressure loss, and 
Gelfoam could easily be deployed. 
 
15.0   DISCUSSION 
 
Looking back on the design process, we had many great successes and a few weaknesses 
in our final design.  However, having been given the broad task of designing a whole 
kidney biopsy device, I believe that our creativity and technical knowledge led us to 
create a truly innovative, successful design.  With some future work, this device will be 
useful in the medical field for biopsies.  This section describes the weaknesses of our 
device, and what we would have done differently to improve the design. 
 
15.1   Weaknesses 
 
The first change we would have made would have been to the inner needle collection site.  
We were charged with the task of designing and prototyping a needle that contained both 
a collection site, and a channel running down its length to carry a hydraulic fluid.  This 
needle also needed to be no bigger than 1.65 mm in diameter.  Our solution to this 
problem, for the prototype, was to form a collection site into a 1.65 mm diameter hollow 
stainless steel tube.  We did this by heating the steel, and pressing a collection site into 
the distal end of the needle.  This was not an adequate method, as the tolerances were 
very large, and the steel was cracked and weakened in the site.  Because of this, we were 
never able to collect a decent sample.  Also, because of the leaks in the collection site, we 
were never able to expel Gelfoam through the tip of the needle. 
 
Our solution to this problem is to custom order a 1.65 mm diameter piece of stainless 
steel stock with a channel running down its length.  This allows for the channel size to be 
minimized.  A precise collection site can then be machined using a wire EDM.  We were 
not able to wire EDM our needles because they were completely hollow; cutting into 
them at any depth meant also cutting into the fluid channel.  If a solid needle with a small 
channel on one side can be produced, an inner biopsy needle would be easy to prototype. 
 
Secondly, we did not allow enough room for springs with sufficient spring forces.  In our 
preliminary calculations, we calculated the necessary forces that all of our springs needed 
to output, but we didn’t know how large those springs were going to be.  We had to cut 
the spring used in the retraction mechanism to fit it under the compliant teeth and in the 
process, losing spring force.  This force was needed to complete the operation of the 
device, and the device could never fully finish the retraction stroke when fully loaded 
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with fluid.  To change this, we would have ordered our springs online as soon as we had 
calculated our spring forces.  This would have allowed us to design our device around the 
springs, as they were a crucial element, and one of the few parts that we made no 
modifications; we had to use what we bought. 
 
Thirdly, we would have liked more time to experiment with the compliant mechanisms in 
our device.  We ran calculations given the material that we were planning to use for snap 
fit teeth, but the theoretical values are always going to differ from the experimental by 
some amount.  We determined that there were many more factors in the operation of a 
snap fit than were accounted for in the calculations.  Early on, we frequently broke teeth 
and had teeth wear away very rapidly.  We ended up custom making the teeth on our 
cylinders out of PVC plastic.  However, having known how difficult making compliant 
mechanisms were, we would have delegated more time to strictly experimenting with 
teeth sizes, or redesigned the device to not incorporate compliant mechanisms. 
 
16.0   RECOMMENDATIONS 
 
We recommend that our device be worked on by future teams.  We are excited by the 
results that we got, and believe that with some work, this biopsy device could be finalized 
and put into use after only a few iterations.  These are the recommendations for future 
work that needs to take place. 
 
Firstly, research into a fluid reservoir needs to take place.  In our prototype, we used a 
pre-manufactured syringe.  This was not sufficient, as the coefficient of friction ended up 
being much higher than we had expected.  This caused our device to struggle with 
injecting a fluid.  Also, the syringe we used was too large.  A cylindrical fluid reservoir 
needs to only be as large as the diameter of the needle to inject the correct amount of 
fluid into the cavity left by the biopsy.  Research into possible deployment devices and 
lubrication methods needs to be performed to determine the optimal method for pushing 
fluid through the needle. 
 
Also, iterations of our compliant mechanisms should be performed.  Having the 
compliant teeth hold evenly and firmly is critical to having the device perform the best 
that it can.  Iterations can be performed to optimize the size and material of the teeth.  In 
experimenting with the teeth we had made using 3-D printing, they frequently failed due 
to a bending load, shearing, or from the tips wearing away, leaving them unable to hold 
the edges of our housing.  When we machined the teeth from PVC, these issues were not 
as common, but still occurred. 
 
Gelfoam behavior was another area that could use further research.  We had samples of 
Gelfoam, but we did not have extensive literature or background knowledge of it.  The 
questions that need to be resolved regarding the Gelfoam are as follows: 
1) How can a Gelfoam plug be loaded into the tip of the needle? 
2) Can a needle be manufactured with a Gelfoam plug preloaded so that it doesn’t 
need to be manually inserted? 
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3) What is the shelf life of Gelfoam?  Will a preloaded Gelfoam plug expire if a 
biopsy device is not used for a long period of time? 
 
Lastly, we plan on this device being re-usable.  After discussions with Dr. Weitzel and 
after having witnessed a live biopsy, we believe the design of a device with disposable 
needles and a reusable housing would be a great improvement in cost and environmental 
impact.  Therefore the interface between the needles and the housing needs to be 
redesigned for easy loading and reloading, and the housing itself must be designed with 
sterilization in mind.   
 
17.0   CONCLUSIONS 
 
This biopsy device design has the potential to make improvements in the field of 
Nephrology.  A biopsy device with bleeding control would give Nephrologists 
confidence when performing kidney biopsy procedures, allowing patients at high risk of 
bleeding to receive accurate and quick treatment.  Dr. Weitzel’s biopsy device design 
proposal is a biopsy device with a hemostatic agent deployment mechanism, which 
would stop bleeding at the biopsy site.  However, no specific deployment mechanism 
currently exists. 
 
To make a successful design of Dr. Weitzel’s concept, the team first researched related 
biopsy methods, biopsy devices, and hemostatic methods.  Dr. Weitzel provided an 
extensive library of patents and articles that were relevant to the objectives of the design.   
These were used as benchmarks to determine the bounds that the design could possibly 
span.  Fully researching these concepts was necessary to find the current related 
technologies used in the medical field today, which was helpful in creating innovative 
concept ideas. 
 
In meeting with Dr. Weitzel, the team determined exactly what customer needs are 
crucial for a biopsy device.  The needs were listed in a QFD diagram in order to 
determine the importance of the engineering specifications of the design.  In performing 
this analysis, the customer needs remained the main focus during concept brainstorming. 
 
From the benchmarking and QFD analysis, the team came up with over 10 concepts for 
needle tips and deployment mechanisms.  After our first design review, we received 
feedback from Dr. Weitzel and were able to draw upon our concept sketches to create 
three refined concept ideas.  We applied qualitative and quantitative analysis on these 
three ideas to select our alpha design, which is a biopsy device that deploys a hemostatic 
plug using a fluid injection mechanism after collecting the kidney sample.   
 
Once we selected our alpha design, we created CAD models with specific dimensions to 
prepare for the prototyping phase.  We were able to model the entire device in order to 
present it for our design review, and also to begin sending requests for material 
purchases. 
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In order to ensure the right dimensions and materials were chosen for our final design, a 
majority of our design review 3 efforts consisted of physical testing of the forces 
involved in a biopsy procedure.  We used our measured forces to determine the internal 
stresses and forces within a biopsy device during operation.  We were able to take these 
values to analyze which materials would be the most appropriate for our particular device 
and manufacturing applications.  We decided that Delrin plastic and type 304 Stainless 
Steel would be the two materials used.  
 
We have fabricated and assembled our prototype and verified its functionality through 
validation testing.  Tests were conducted to verify the device’s deployment mechanism, 
retraction mechanism, and fluid deployment system, along with the feasibility of 
Gelfoam injection via a needle.  All tests were separately satisfied and we believe a more 
robust manufacturing process (as would be used in mass production) would allow the 
complete functionality of our device. 
 
From the results of our tests, we are confident that our device will perform as we 
designed.  With further research as suggested, our device will make kidney biopsies a 
much safer procedure, and doctors will not be hesitant to biopsy a patient at high risk of 
excessive bleeding after the procedure.  This will result in more accurate diagnosis of 
renal disease, and more effective treatment of people affected by these diseases. 
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APPENDIX C: SNAP FIT ANALYSIS 
 
For an arbitrary snap fit connection, 
 
 
The table below incorporates the mechanical governing equations for each of the values.  This is 
the table we used to determine our geometrical values and materials. 
 
ME 450 Snap Fit Design Analysis  
    








height,  h (mm) 1.25 1.25 1.25 
length, L (mm) 11 11 11 
base width, b (mm) 5 5 5 
deflection, y (mm) 1 1 1.25 
insertion angle, α (rad) 0.643501109 0.643501109 0.558599315 
insertion angle, α (°) 36.86989765 36.86989765 32.00538321 
Young's modulus, E (GPa) 2.5 2.5 2.5 
coefficient of friction, μ 0.3 0.3 0.3 
permissible strain, ε 
(mm/mm) 0.015495868 0.015495868 0.019369835 
yield strain (mm/mm) 0.036894923 0.036894923 0.046118654 
    
deflect force, P (N) 4.585661627 4.585661627 5.732077033 
insert force, Fi (N) 6.212831881 6.212831881 6.525749238 
    
Force to release mechanism 
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APPENDIX D: FLUID VOLUME ANALYSIS 
 
Below is the table of fluid volumes for each component of the biopsy device. 
 
VOLUME OF FLUID CHAMBER 
(V_chamber) 
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A – Upper half of housing 
Team 10   70 
 
 





C – Deployment button 
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E – Inner collection needle outer cylinder push rod 
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H – Inner collection needle outer cylinder 














J - Outer cutting sheath outer cylinder 
Team 10   74 
 
 










L – Outer cutting sheath outer cylinder push rod 
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O – Hydraulic Plunger 
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Q – Push plate 
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Type 304 Stainless Steel Properties 
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APPENDIX G:  GELFOAM® PREPARATION PROCEDURE 
 
A. Preparation of Gelfoam® absorbable gelatin compressed sponge  
• When used in a fluid ejection system, sterile saline solution is to act as the fluid. 
• Desired quantity of Gelfoam® should be first immersed in solution.   
• Remove Gelfoam® from solution and squeeze to manually expel air bubbles 
• Place it back in saline until needed; Gelfoam® should return to original size with 
slight increase in thickness and shape when in saline. 
 
B. Preparation for Gelfoam® absorbable gelatin powder 
• Gelfoam® powder can be purchased in 1-gram envelopes, or created by milling and 
sterilizing an absorbable gelatin compressed sponge. 
• Carefully pour one envelope (1 gram) of powder into sterile beaker 
• Add 3-4 mL of sterile saline to form thick paste 
o Note: to prevent dispersion of the powder when saline is added, compressing 
the powder into the bottom of the bottom of the beaker.  After saline is added, 
knead to desired consistency. 
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